3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Carcinoma, Non-Small-Cell Lung
5
Recurrence
3
Neoplasm Metastasis
3
Melanoma
3
Prostatic Neoplasms
2
Pancreatic Neoplasms
2
Cutaneous Squamous Cell Carcinoma
2
Carcinoma, Basal Cell
2
Uterine Cervical Neoplasms
1
Urinary Bladder Neoplasms
1
Triple Negative Breast Neoplasms
1
Stomach Neoplasms
1
Squamous Cell Carcinoma of Head and Neck
1
Ovarian Neoplasms
1
Neoplasms
1
Multiple Myeloma
1
Lymphoma
1
Head and Neck Neoplasms
1
Glioma
1
Glioblastoma
1
Diffuse Intrinsic Pontine Glioma
1
Colorectal Neoplasms
1
Colonic Neoplasms
1
Central Nervous System Neoplasms
1
Carcinoma, Squamous Cell
1
Carcinoma, Merkel Cell
1
Breast Neoplasms
1
Advanced Non-Small Cell Lung Carcinoma
1
Adenocarcinoma
1
Interventions
Sorafenib
23
Bevacizumab
11
Radiosurgery
6
Capecitabine
6
Radiofrequency Ablation
5
Oxaliplatin
5
Fluorouracil
5
Doxorubicin
5
pembrolizumab
4
Sunitinib
4
Erlotinib Hydrochloride
4
Cisplatin
4
Ramucirumab
3
Radiotherapy
3
Nivolumab
3
Leucovorin
3
Carboplatin
3
tremelimumab
2
spartalizumab
2
perflutren
2
derazantinib
2
carotuximab
2
Mitomycin
2
Magnetic Resonance Spectroscopy
2
Magnetic Resonance Imaging
2
Ipilimumab
2
Immunohistochemistry
2
Gemcitabine
2
Folfox protocol
2
Fluorodeoxyglucose F18
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Liver Neoplasms
×
cemiplimab
×
Clear all
No trials found.